Plexera inks DNA-based protein chip deal
Plexera Biosciences is hoping to leave its rivals in its wake following an exclusive option agreement for Auguron Biosciences' DNA-based protein chips.
Plexera Biosciences is hoping to leave its rivals in its wake following an exclusive option agreement for Auguron Biosciences' DNA-based protein chips.
Pharmaceutical Product Development (PPD) has initiated central laboratory services in China in response to the country's budding clinical trials scene.
At this week's Informex show in New Orleans, experts at a packed out session discussed the potential of up-and-coming continuous processing technologies and posed the question: is batch processing yesterday's technology?
US contract manufacturer Catalent Pharma Solutions has leveraged its partnership with Secure Symbology (SSI) for track and trace barcode technology to help biopharmaceutical company Biogen Idec comply with California's pending ePedigree law.